Reiding K - Search Results

1

IgG and IgM glycosylation patterns in patients undergoing image-guided tumor ablation.

Breen LD, Pučić-Baković M, Vučković F, Reiding K, Trbojević-Akmačić I, Šrajer Gajdošik M, Cook MI, Lopez MJ, Wuhrer M, Camara LM, Andjelković U, Dupuy DE, Josić D. Breen LD, et al. Among authors: reiding k. Biochim Biophys Acta. 2016 Aug;1860(8):1786-94. doi: 10.1016/j.bbagen.2016.01.011. Epub 2016 Jan 29. Biochim Biophys Acta. 2016. PMID: 26827872

2

Oxonium Ion-Guided Optimization of Ion Mobility-Assisted Glycoproteomics on the timsTOF Pro.

Mukherjee S, Jankevics A, Busch F, Lubeck M, Zou Y, Kruppa G, Heck AJR, Scheltema RA, Reiding KR. Mukherjee S, et al. Mol Cell Proteomics. 2023 Feb;22(2):100486. doi: 10.1016/j.mcpro.2022.100486. Epub 2022 Dec 19. Mol Cell Proteomics. 2023. PMID: 36549589 Free PMC article.

3

High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification.

Reiding KR, Blank D, Kuijper DM, Deelder AM, Wuhrer M. Reiding KR, et al. Anal Chem. 2014 Jun 17;86(12):5784-93. doi: 10.1021/ac500335t. Epub 2014 May 28. Anal Chem. 2014. PMID: 24831253

4

Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.

Bondt A, Rombouts Y, Selman MH, Hensbergen PJ, Reiding KR, Hazes JM, Dolhain RJ, Wuhrer M. Bondt A, et al. Mol Cell Proteomics. 2014 Nov;13(11):3029-39. doi: 10.1074/mcp.M114.039537. Epub 2014 Jul 8. Mol Cell Proteomics. 2014. PMID: 25004930 Free PMC article.

5

High-Throughput Analysis and Automation for Glycomics Studies.

Shubhakar A, Reiding KR, Gardner RA, Spencer DI, Fernandes DL, Wuhrer M. Shubhakar A, et al. Chromatographia. 2015;78(5-6):321-333. doi: 10.1007/s10337-014-2803-9. Epub 2014 Nov 16. Chromatographia. 2015. PMID: 25814696 Free PMC article. Review.

6

Automation of High-Throughput Mass Spectrometry-Based Plasma N-Glycome Analysis with Linkage-Specific Sialic Acid Esterification.

Bladergroen MR, Reiding KR, Hipgrave Ederveen AL, Vreeker GC, Clerc F, Holst S, Bondt A, Wuhrer M, van der Burgt YE. Bladergroen MR, et al. J Proteome Res. 2015 Sep 4;14(9):4080-6. doi: 10.1021/acs.jproteome.5b00538. Epub 2015 Aug 11. J Proteome Res. 2015. PMID: 26179816

7

Linkage-specific sialic acid derivatization for MALDI-TOF-MS profiling of IgG glycopeptides.

de Haan N, Reiding KR, Haberger M, Reusch D, Falck D, Wuhrer M. de Haan N, et al. Anal Chem. 2015 Aug 18;87(16):8284-91. doi: 10.1021/acs.analchem.5b02426. Epub 2015 Jul 31. Anal Chem. 2015. PMID: 26191964

8

Plasma N-Glycome Signature of Down Syndrome.

Borelli V, Vanhooren V, Lonardi E, Reiding KR, Capri M, Libert C, Garagnani P, Salvioli S, Franceschi C, Wuhrer M. Borelli V, et al. J Proteome Res. 2015 Oct 2;14(10):4232-45. doi: 10.1021/acs.jproteome.5b00356. Epub 2015 Sep 14. J Proteome Res. 2015. PMID: 26334954

9

A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.

Rouwendal GJ, van der Lee MM, Meyer S, Reiding KR, Schouten J, de Roo G, Egging DF, Leusen JH, Boross P, Wuhrer M, Verheijden GF, Dokter WH, Timmers M, Ubink R. Rouwendal GJ, et al. MAbs. 2016;8(1):74-86. doi: 10.1080/19420862.2015.1102812. Epub 2015 Oct 6. MAbs. 2016. PMID: 26440530 Free PMC article.

10

Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting.

Meyer S, Nederend M, Jansen JH, Reiding KR, Jacobino SR, Meeldijk J, Bovenschen N, Wuhrer M, Valerius T, Ubink R, Boross P, Rouwendal G, Leusen JH. Meyer S, et al. MAbs. 2016;8(1):87-98. doi: 10.1080/19420862.2015.1106658. Epub 2015 Oct 14. MAbs. 2016. PMID: 26466856 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page